CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 121 enrolled
Drug / intervention
PillCam SB2 capsule +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01787825
NCT01787825N/ACompleted
CompareCT.gov

Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease

Capso Vision, Inc.·interventional·Posted Feb 11, 2013·Updated May 10, 2017

In Brief

A clinical study evaluating PillCam SB2 capsule and CapsoCam SV-1 for Intestinal Disease and 4 related conditions. Completed, enrolled 121 participants across 7 sites in 2 countries.

Detailed Summary

The purpose of this study is to compare the clinical findings involving the small bowel obtained with the Capso Vision Video Capsule Device to those results obtained with the PillCam SB2.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntestinal Disease, Inflammatory Bowel Disease, Crohn Disease, Ulcer, Celiac Disease
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 11, 2013
Enrollment StartMay 1, 2012
Primary CompletionApr 1, 2015
Study CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 13.4 years ago

Interventions

PillCam SB2 capsuledevice

Capsule Endoscopy system

CapsoCam SV-1device

Capsule endoscopy